Anti-Human SELP Recombinant Antibody(Crizanlizumab)

Name: Anti-Human SELP Recombinant Antibody(Crizanlizumab)
Brand: KMD Bioscience
SKU: YR1442

YR1442

科研级 Crizanlizumab ( 立赞利珠单抗 ), Anti-SELP Recombinant Antibody, Research Grade Crizanlizumab

DATASHEET MSDS

Product Description

Alias	科研级 Crizanlizumab ( 立赞利珠单抗 ), Anti-SELP Recombinant Antibody, Research Grade Crizanlizumab
Catalog Number	YR1442
Molecular Name	Crizanlizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Crizanlizumab, sold under the brand name Adakveo, is a monoclonal antibody medication developed by Novartis targeted towards P-selectin. It was announced by the company as an effective drug to prevent vaso-occlusive crisis in patients with sickle cell anemia. The result of the Phase II SUSTAIN clinical trial was published in December 2016.
CAS Number	1690318-25-2
Application	ELISA, IHC, IF, IP, FCM, FuncS
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	SELP[Homo sapiens]

Login